Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128888) titled 'Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection' on Aug. 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Gan & Lee Pharmaceuticals.
Condition:
Obesity
Intervention:
Drug: GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: November 17, 2025
Target Sample Size: 60
Countries of Recruitment:
China
To know more, visit https://clinical...